Recent findings from the RESOLVE-1 trial highlight mycophenolate mofetil's efficacy in treating diffuse cutaneous systemic ...
New research recommends that clinicians screen for foot peripheral sensory neuropathy during initial assessments for patients with systemic sclerosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback